The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism
Julia Möllmann; Florian Kahles; Corinna Lebherz; Ben Kappel; Christer Baeck; Frank Tacke; Christian Werner; Massimo Federici; Nikolaus Marx; Michael Lehrke
Author Information: Department of Internal Medicine I
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.